Semaglutide, Liraglutide May Reduce Hospitalization Risk for Alcohol Use Disorder

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 22, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, Nov. 22, 2024 -- Semaglutide and liraglutide are associated with a reduced risk for hospitalization due to alcohol use disorder (AUD), according to a study published online Nov. 13 in JAMA Psychiatry.

Markku Lähteenvuo, M.D., Ph.D., from the University of Eastern Finland in Kuopio, and colleagues conducted an observational study in Sweden using data from January 2006 to December 2023 to examine whether the risk for hospitalization due to AUD is decreased during use of glucagon-like peptide-1 (GLP-1) receptor agonists versus nonuse in the same individual. The cohort included 227,866 individuals with AUD, who were followed for a median of 8.8 years.

The researchers found that 58.5 percent of the individuals experienced AUD hospitalization. The lowest risks for AUD and substance use disorder (SUD) hospitalization were seen in association with semaglutide use (adjusted hazard ratios, 0.64 and 0.68 for AUD and any SUD, respectively) and liraglutide use (adjusted hazard ratios, 0.72 and 0.78, respectively). A modestly decreased risk was seen in association with use of any AUD medication (adjusted hazard ratio, 0.98). Reductions in the risk for somatic hospitalizations were also seen in association with semaglutide and liraglutide use (adjusted hazard ratios, 0.78 and 0.79, respectively), but there was no association with suicide attempts.

"AUDs and SUDs are undertreated pharmacologically, despite the availability of effective treatments," the authors write. "GLP-1 agonists, and especially semaglutide and liraglutide, may be effective in the treatment of AUD."

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-11-23 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords